Clinical trial
Salvage High Dose Rate Brachytherapy for Local Recurrence in Prostate Cancer: A Phase II Trial
NCT04231006 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Salvage High Dose Rate Brachytherapy for Local Recurrence in Prostate Cancer: A Phase II Trial
- Lead sponsor
- Aarhus University Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 1, 2021
- Completion date
- March 1, 2035
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer